Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
408 | 29468 | 39.3 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
408 | 3 | CHIM BIOINORGAN//POLO SCI//CARBONIC ANHYDRASE | 29468 |
1363 | 2 | TIRAPAZAMINE//DT DIAPHORASE//BIOREDUCTIVE DRUGS | 8244 |
1816 | 2 | INTERNATIONAL JOURNAL OF HYPERTHERMIA//HYPERTHERMIA//ISOLATED LIMB PERFUSION | 6226 |
2150 | 2 | HIF 1 ALPHA//HYPOXIA INDUCIBLE FACTOR//HIF 1 | 5019 |
2256 | 2 | CARBONIC ANHYDRASE//CHIM BIOINORGAN//POLO SCI | 4686 |
2612 | 2 | WARBURG EFFECT//PKM2//PYRUVATE KINASE | 3575 |
3350 | 2 | VDAC//VOLTAGE DEPENDENT ANION CHANNEL//HEXOKINASE | 1718 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CHIM BIOINORGAN | address | 3017117 | 12% | 85% | 547 |
2 | POLO SCI | address | 699429 | 3% | 70% | 153 |
3 | CARBONIC ANHYDRASE | authKW | 647871 | 5% | 47% | 1122 |
4 | NEUROFARBA | address | 567747 | 4% | 43% | 205 |
5 | INTERNATIONAL JOURNAL OF HYPERTHERMIA | journal | 536857 | 4% | 48% | 920 |
6 | SEZ SCI FARMACEUT | address | 491264 | 2% | 93% | 81 |
7 | SEZ SCI FARMACEUT NUTRACEUT | address | 421001 | 2% | 91% | 71 |
8 | DIPARTIMENTO NEUROFARBA | address | 348373 | 1% | 82% | 65 |
9 | SECT PHARMACEUT NUTRICEUT SCI | address | 321027 | 1% | 93% | 53 |
10 | HYPOXIA | authKW | 303963 | 9% | 11% | 2200 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 122348 | 37% | 1% | 9159 |
2 | Radiology, Nuclear Medicine & Medical Imaging | 43572 | 17% | 1% | 4240 |
3 | Biochemistry & Molecular Biology | 17183 | 25% | 0% | 6212 |
4 | Chemistry, Medicinal | 12008 | 7% | 1% | 1787 |
5 | Cell Biology | 10170 | 12% | 0% | 3014 |
6 | Biophysics | 8633 | 8% | 1% | 1926 |
7 | Biology | 3707 | 4% | 0% | 1029 |
8 | Medicine, Research & Experimental | 2151 | 5% | 0% | 1157 |
9 | Pharmacology & Pharmacy | 1586 | 7% | 0% | 1831 |
10 | Physiology | 923 | 3% | 0% | 782 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHIM BIOINORGAN | 3017117 | 12% | 85% | 547 |
2 | POLO SCI | 699429 | 3% | 70% | 153 |
3 | NEUROFARBA | 567747 | 4% | 43% | 205 |
4 | SEZ SCI FARMACEUT | 491264 | 2% | 93% | 81 |
5 | SEZ SCI FARMACEUT NUTRACEUT | 421001 | 2% | 91% | 71 |
6 | DIPARTIMENTO NEUROFARBA | 348373 | 1% | 82% | 65 |
7 | SECT PHARMACEUT NUTRICEUT SCI | 321027 | 1% | 93% | 53 |
8 | CHIM INORGAN BIOINORGAN | 185638 | 1% | 41% | 69 |
9 | CHIM BIOORGAN | 153584 | 3% | 18% | 128 |
10 | IST BIOSCI BIORISORSE | 125976 | 1% | 54% | 36 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF HYPERTHERMIA | 536857 | 4% | 48% | 920 |
2 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 72333 | 4% | 6% | 1016 |
3 | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 35785 | 1% | 12% | 239 |
4 | RADIATION RESEARCH | 29499 | 2% | 6% | 401 |
5 | BRITISH JOURNAL OF CANCER | 22164 | 2% | 3% | 579 |
6 | CANCER RESEARCH | 18397 | 3% | 2% | 788 |
7 | INTERNATIONAL JOURNAL OF RADIATION BIOLOGY | 13855 | 1% | 5% | 242 |
8 | RADIOTHERAPY AND ONCOLOGY | 12923 | 1% | 4% | 254 |
9 | CANCER CLINICAL TRIALS | 6456 | 0% | 20% | 26 |
10 | ANTI-CANCER DRUG DESIGN | 6051 | 0% | 9% | 56 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARBONIC ANHYDRASE | 647871 | 5% | 47% | 1122 | Search CARBONIC+ANHYDRASE | Search CARBONIC+ANHYDRASE |
2 | HYPOXIA | 303963 | 9% | 11% | 2200 | Search HYPOXIA | Search HYPOXIA |
3 | HYPERTHERMIA | 218273 | 4% | 19% | 941 | Search HYPERTHERMIA | Search HYPERTHERMIA |
4 | CARBONIC ANHYDRASE INHIBITORS | 178214 | 2% | 35% | 79 | Search CARBONIC+ANHYDRASE+INHIBITORS | Search CARBONIC+ANHYDRASE+INHIBITORS |
5 | HIF 1 ALPHA | 174959 | 2% | 30% | 471 | Search HIF+1+ALPHA | Search HIF+1+ALPHA |
6 | HYDRATASE ACTIVITY | 163099 | 1% | 96% | 26 | Search HYDRATASE+ACTIVITY | Search HYDRATASE+ACTIVITY |
7 | BETA CLASS ENZYME | 162860 | 1% | 100% | 25 | Search BETA+CLASS+ENZYME | Search BETA+CLASS+ENZYME |
8 | HYPOXIA INDUCIBLE FACTOR | 157506 | 1% | 36% | 352 | Search HYPOXIA+INDUCIBLE+FACTOR | Search HYPOXIA+INDUCIBLE+FACTOR |
9 | VDAC | 135590 | 1% | 69% | 161 | Search VDAC | Search VDAC |
10 | TUMOR HYPOXIA | 131397 | 1% | 60% | 177 | Search TUMOR+HYPOXIA | Search TUMOR+HYPOXIA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SUPURAN, CT , DE SIMONE, G , ALTERIO, V , DI FIORE, A , D'AMBROSIO, K , (2012) MULTIPLE BINDING MODES OF INHIBITORS TO CARBONIC ANHYDRASES: HOW TO DESIGN SPECIFIC DRUGS TARGETING 15 DIFFERENT ISOFORMS?.CHEMICAL REVIEWS. VOL. 112. ISSUE 8. P. 4421 -4468 | 220 | 75% | 103 |
2 | SUPURAN, CT , (2016) HOW MANY CARBONIC ANHYDRASE INHIBITION MECHANISMS EXIST?.JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. VOL. 31. ISSUE 3. P. 345 -360 | 157 | 96% | 6 |
3 | KRISHNAMURTHY, VM , KAUFMAN, GK , URBACH, AR , GITLIN, I , GUDIKSEN, KL , WEIBEL, DB , WHITESIDES, GM , (2008) CARBONIC ANHYDRASE AS A MODEL FOR BIOPHYSICAL AND PHYSICAL-ORGANIC STUDIES OF PROTEINS AND PROTEIN-LIGAND BINDING.CHEMICAL REVIEWS. VOL. 108. ISSUE 3. P. 946 -1051 | 315 | 48% | 260 |
4 | SUPURAN, CT , (2017) ADVANCES IN STRUCTURE-BASED DRUG DISCOVERY OF CARBONIC ANHYDRASE INHIBITORS.EXPERT OPINION ON DRUG DISCOVERY. VOL. 12. ISSUE 1. P. 61 -88 | 178 | 96% | 0 |
5 | PASTOREK, J , PASTOREKOVA, S , (2015) HYPOXIA-INDUCED CARBONIC ANHYDRASE IX AS A TARGET FOR CANCER THERAPY: FROM BIOLOGY TO CLINICAL USE.SEMINARS IN CANCER BIOLOGY. VOL. 31. ISSUE . P. 52 -64 | 141 | 83% | 27 |
6 | KEITH, B , JOHNSON, RS , SIMON, MC , (2012) HIF1 ALPHA AND HIF2 ALPHA: SIBLING RIVALRY IN HYPOXIC TUMOUR GROWTH AND PROGRESSION.NATURE REVIEWS CANCER. VOL. 12. ISSUE 1. P. 9 -22 | 123 | 67% | 378 |
7 | WALSH, JC , LEBEDEV, A , ATEN, E , MADSEN, K , MARCIANO, L , KOLB, HC , (2014) THE CLINICAL IMPORTANCE OF ASSESSING TUMOR HYPOXIA: RELATIONSHIP OF TUMOR HYPOXIA TO PROGNOSIS AND THERAPEUTIC OPPORTUNITIES.ANTIOXIDANTS & REDOX SIGNALING. VOL. 21. ISSUE 10. P. 1516 -1554 | 199 | 71% | 20 |
8 | SEMENZA, GL , (2003) TARGETING HIF-1 FOR CANCER THERAPY.NATURE REVIEWS CANCER. VOL. 3. ISSUE 10. P. 721-732 | 81 | 79% | 3268 |
9 | EBBESEN, P , PETTERSEN, EO , GORR, TA , JOBST, G , WILLIAMS, K , KIENINGER, J , WENGER, RH , PASTOREKOVA, S , DUBOIS, L , LAMBIN, P , ET AL (2009) TAKING ADVANTAGE OF TUMOR CELL ADAPTATIONS TO HYPOXIA FOR DEVELOPING NEW TUMOR MARKERS AND TREATMENT STRATEGIES.JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. VOL. 24. ISSUE . P. 1 -39 | 234 | 70% | 39 |
10 | BASS, PD , GUBLER, DA , JUDD, TC , WILLIAMS, RM , (2013) MITOMYCINOID ALKALOIDS: MECHANISM OF ACTION, BIOSYNTHESIS, TOTAL SYNTHESES, AND SYNTHETIC APPROACHES.CHEMICAL REVIEWS. VOL. 113. ISSUE 8. P. 6816-6863 | 184 | 72% | 33 |
Classes with closest relation at Level 3 |